Chemomab Therapeutics Ltd. — Director's Dealing 2021

Mar 25, 2021

SEC Form 3 — Initial Statement of Beneficial Ownership

Issuer: Chemomab Therapeutics Ltd. (CMMB)
CIK: 0001534248
Period of Report: 2021-03-16

Reporting Person: Aharon Arnon (Chief Medical Officer)

Holdings (Derivative)

Security	Exercise Price	Expiration	Underlying	Shares	Ownership
Option to purchase American Depositary Shares	$1.49	2027-12-03	American Depositary Shares (13274)		Direct
Option to purchase American Depositary Shares	$1.62	2029-12-16	American Depositary Shares (61958)		Direct

Footnotes

F1: 10,779 of these options to purchase American Depositary Share (ADSs) have vested and are exercisable as of the date hereof, and the remaining 2,495 of these options will vest and become exercisable in three remaining installments, with 1/3 of such options vesting on each three month anniversary commencing on of June 4, 2021, subject to the Reporting Person's continued service.

F2: Each ADS represents twenty (20) ordinary shares, no par value, of the Issuer.

F3: 30,973 of these options to purchase ADSs have vested and are exercisable as of the date hereof, and the remaining 30,985 of these options will vest and become exercisable in eight remaining installments, with 12.5% of such options vesting on each three month anniversary commencing on May 28, 2021, subject to the Reporting Person's continued service.